The End of Compounded Semaglutide: Why the FDA’s Decision Matters for Patients and Pharmacies
Updated: 2025-02-26 15:39:00
The U.S. Food and Drug Administration (FDA) has recently declared an end to the shortage of semaglutide, the active ingredient in popular weight-loss medications like Ozempic and Wegovy. This decision...
The post The End of Compounded Semaglutide: Why the FDA’s Decision Matters for Patients and Pharmacies appeared first on Seattle Plastic Surgery | Best Seattle Cosmetic Surgeon.